Literature DB >> 8832770

No association between chromosome-18 markers and lithium-responsive affective disorders.

G Turecki1, M Alda, P Grof, R Martin, P A Cavazzoni, A Duffy, P Maciel, G A Rouleau.   

Abstract

An allelic association study of excellent responders to lithium was conducted with a candidate gene (Golf, a G-protein receptor gene) and five other chromosome-18p markers. Golf is of special interest because it maps to a region of chromosome 18 where two independent groups (Berrettini et al., 1994; Stine et al., 1995) have found linkage to bipolar disorder. It has been proposed that G proteins are involved in the pathogenesis of bipolar disorder, and lithium, an effective prophylactic agent, is known to impair G-protein activation. To reduce heterogeneity--a common obstacle to genetic investigation--only patients who showed excellent response to lithium prophylaxis were studied. Fifty-five genetically unrelated excellent responders to lithium prophylaxis were compared with 94 normal subjects of similar ethnic background. The groups did not differ in either allele or genotype frequency for the tested markers. The data do not support the hypothesis that the tested loci confer a major susceptibility for affective disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832770     DOI: 10.1016/0165-1781(96)02864-8

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

Review 1.  The promise and reality of pharmacogenetics in psychiatry.

Authors:  Peter P Zandi; Jennifer T Judy
Journal:  Psychiatr Clin North Am       Date:  2010-03

Review 2.  Pharmacogenetics of bipolar disorder.

Authors:  Hader A Mansour; Martin Alda; Vishwajit L Nimgaonkar
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 3.  Pharmacogenetics of lithium response in bipolar disorder.

Authors:  M Alda
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

Review 4.  Response to treatment in bipolar disorder.

Authors:  Cristiana Cruceanu; Martin Alda; Guy Rouleau; Gustavo Turecki
Journal:  Curr Opin Psychiatry       Date:  2011-01       Impact factor: 4.741

Review 5.  The role of G proteins in the psychobiology and treatment of affective disorders and their integration with the neurotransmitter hypothesis.

Authors:  S Avissar
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

6.  Investigation of the G protein subunit Galphaolf gene (GNAL) in attention deficit/hyperactivity disorder.

Authors:  Nancy Laurin; Abel Ickowicz; Tejaswee Pathare; Molly Malone; Rosemary Tannock; Russell Schachar; James L Kennedy; Cathy L Barr
Journal:  J Psychiatr Res       Date:  2006-12-12       Impact factor: 4.791

7.  No evidence for significant linkage between bipolar affective disorder and chromosome 18 pericentromeric markers in a large series of multiplex extended pedigrees.

Authors:  J A Knowles; P A Rao; T Cox-Matise; J E Loth; G M de Jesus; L Levine; K Das; G K Penchaszadeh; J R Alexander; B Lerer; J Endicott; J Ott; T C Gilliam; M Baron
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

Review 8.  Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.

Authors:  Firoza Mamdani; Iris Jaitovich Groisman; Martin Alda; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.